Last update 05 Mar 2026

Eldec Pharmaceuticals, Inc.

Private Company|2019|North Carolina, United States|
eldecpharmaceuticals.com

Overview

Basic Info

Introduction
Established by the entrepreneurial efforts of Drs. Saira Ahmad, Flori Sassano, and Robert Tarran, Eldec Pharmaceuticals Inc. emerged from UNC-CH in 2017. Research from Dr. Tarran's lab, focusing on SPLUNC1's impact on chronic lung inflammation, was pivotal in the company's inception. Dr. Tarran identified a key C-terminal SPLUNC1 sequence that regulates the Orai1 Ca2+ channel in immune cells, laying the foundation for Eldec's primary drug development initiative.

Tags

Infectious Diseases
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
BPIFA1 x ORAI11

Related

1
Drugs associated with Eldec Pharmaceuticals, Inc.
ELD-607
Target
BPIFA1 x ORAI1
Mechanism
BPIFA1 stimulators [+1]
Active Org.
Eldec Pharmaceuticals, Inc.
Originator Org.
Eldec Pharmaceuticals, Inc.
Active Indication
Enterobacter Infection [+5]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Eldec Pharmaceuticals, Inc.
Login to view more data
0 Patents (Medical) associated with Eldec Pharmaceuticals, Inc.
Login to view more data
100 Deals associated with Eldec Pharmaceuticals, Inc.
Login to view more data
100 Translational Medicine associated with Eldec Pharmaceuticals, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 16 Mar 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
ELD-607
 ( BPIFA1 x ORAI1 )		Enterobacter Infection
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free